TLR2 and TLR4 Gene Polymorphisms and Atopic Dermatitis in Italian Children: A Multicenter Study

International Journal of Immunopathology and Pharmacology

Volumn 24, Issue , 2011, Pages 33-40

  Salpietro, C ^a   Rigoli, L ^a   Del Giudice, Miraglia M ^b   Cuppari, C ^a   Di Bella, C ^a   Salpietro, A ^a   Maiello, N ^b   La Rosa, M ^c   Marseglia, G L ^d   Leonardi, S ^c   Briuglia, S ^a   Ciprandi, Giorgio ^e  

^a UNIVERSITY OF MESSINA   (Italy)

^b SECOND UNIVERSITY OF NAPLES   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF PAVIA   (Italy)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Atopic dermatitis; polymorphism; Toll like receptor 2 gene; Toll like receptor 4 gene

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; DNA; IMMUNOGLOBULIN E; TLR2 PROTEIN, HUMAN; TLR4 PROTEIN, HUMAN;

ARTICLE; ATOPIC DERMATITIS; CHILD; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENE FREQUENCY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; INFANT; ITALIAN (CITIZEN); MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SCORING ATOPIC DERMATITIS; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN DISEASE ASSESSMENT; ALLELE; CLINICAL TRIAL; GENETICS; GENOTYPE; ITALY; MULTICENTER STUDY; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ALLELES; CHILD; CHILD, PRESCHOOL; DERMATITIS, ATOPIC; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; IMMUNOGLOBULIN E; INFANT; ITALY; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 4;

EID: 84856499751     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/03946320110240S408     Document Type: Article

References (41)

1. Williams H, Robertson C, Stewart A, Aït-Khaled N, Anabwani G, Anderson R, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol 1999; 103 (1 Pt 1): 125-38.
2. Boguniewicz M, Leung DY,. Atopic dermatitis: A disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242 (1): 233-46.
3. Larsen FS, Holm NV, Henningsen K,. Atopic dermatitis. A genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1986; 15 (3): 487-94.
4. Williams HC,. Epidemiology of atopic dermatitis. Clin Exp Dermatol 2000; 25 (7): 522-9.
5. Borchers AT, Keen CL, Gershwin ME,. Hope for the hygiene hypothesis: When the dirt hits the fan. J Asthma 2005; 42 (4): 225-47.
6. Kabesch M, Lauener RP,. Why Old McDonald had a farm but no allergies: Genes, environments, and the hygiene hypothesis. J Leukoc Biol. 2004; 75 (3): 383-7.
7. Janeway CA Jr, Medzhitov R,. Innate immune recognition. Annu Rev Immunol 2002; 20: 197-216.
8. Akira S,. Toll-like receptor signaling. J Biol Chem 2003; 278 (40): 38105-8.
9. Takeda K, Akira S,. TLR signaling pathways. Semin Immunol 2004; 16 (1): 3-9.
10. Dorschner RA, Pestonjamasp VK, Tamakuwala S, Ohtake T, Rudisill J, Nizet V, et al. Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus. J Invest Dermatol 2001; 117 (1): 91-7.
11. Ali RS, Falconer A, Ikram M, Bissett CE, Cerio R, Quinn AG,. Expression of the peptide antibiotics human beta defensin-1 and human beta defensin-2 in normal human skin. J Invest Dermatol 2001; 117 (1): 106-11.
12. Sugita K, Kabashima K, Atarashi K, Shimauchi T, Kobayashi M, Tokura Y,. Innate immunity mediated by epidermal keratinocytes promotes acquired immunity involving Langerhans cells and T cells in the skin. Clin Exp Immunol 2007; 147 (1): 176-83.
13. Köllisch G, Kalali BN, Voelcker V, Wallich R, Behrendt H, Ring J, et al. Various members of the Toll-like receptor family contribute to the innate immune response of human epidermal keratinocytes. Immunology 2005; 114 (4): 531-41.
14. Begon E, Michel L, Flageul B, Beaudoin I, Jean-Louis F, Bachelez H, et al. Expression, subcellular localization and cytokinic modulation of Toll-like receptors (TLRs) in normal human keratinocytes: TLR2 up-regulation in psoriatic skin. Eur J Dermatol; 17 (6): 497-506.
15. Lebre MC, van der Aar AM, van Baarsen L, van Capel TM, Schuitemaker JH, Kapsenberg ML, et al. Human keratinocytes express functional Toll-like receptor 3, 4, 5, and 9. J Invest Dermatol 2007; 127 (2): 331-41.
16. Kawai K, Shimura H, Minagawa M, Ito A, Tomiyama K, Ito M,. Expression of functional Toll-like receptor 2 on human epidermal keratinocytes. J Dermatol Sci 2002; 30 (3): 185-94.
17. Schumann RR,. Host cell-pathogen interface: Molecular mechanisms and genetics. Vaccine 2004; 22 Suppl 1: S21-4.
18. Girardin SE, Travassos LH, Hervé M, Blanot D, Boneca IG, Philpott DJ, et al. Peptidoglycan molecular requirements allowing detection by Nod1 and Nod2. J Biol Chem 2003; 278 (43): 41702-8.
19. Visser L, Melief MJ, van Riel D, van Meurs M, Sick EA, Inamura S, et al. Phagocytes containing a disease-promoting Toll-like receptor/Nod ligand are present in the brain during demyelinating disease in primates. Am J Pathol 2006; 169 (5): 1671-85.
20. Akira S, Uematsu S, Takeuchi O,. Pathogen recognition and innate immunity. Cell 2006; 124 (4): 783-801
21. Song PI, Park YM, Abraham T, Harten B, Zivony A, Neparidze N, et al. Human keratinocytes express functional CD 14 and toll-like receptor 4. J Invest Dermatol 2002; 119 (2): 424-32.
22. Eder W, Klimecki W, Yu L, von Mutius E, Riedler J, Braun-Fahrlander C, et al.ALEX Study Team. Toll-like receptor 2 as a major gene for asthma in children of European farmers. J Allergy Clin Immunol 2004; 113 (3): 482-8.
23. Ahmad-Nejad P, Mrabet-Dahbi S, Breuer K, Klotz M, Werfel T, Herz U, et al. The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype. J Allergy Clin Immunol 2004; 113 (3): 565-7.
24. Kerkhof M, Postma DS, Brunekreef B, Reijmerink NE, Wijga AH, de Jongste JC, et al. Toll-like receptor 2 and 4 genes influence susceptibility to adverse effects of traffic-related air pollution on childhood asthma. Thorax 2010; 65 (8): 690-7.
25. Werner M, Topp R, Wimmer K, Richter K, Bischof W, Wjst M, et al. TLR4 gene variants modify endotoxin effects on asthma. J Allergy Clin Immunol 2003; 112 (2): 323-30.
26. Akdis CA, Akdis M, Bieber T, Bindslev-Jensen C, Boguniewicz M, Eigenmann P, et al. Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus Report. Allergy 2006; 61 (8): 969-87.
27. Severity scoring of atopic dermatitis: The SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis. Dermatology 1993; 186 (1): 23-31.
28. Skin tests used in type I allergy testing Position paper. Sub-Committee on Skin Tests of the European Academy of Allergology and Clinical Immunology. Allergy 1989; 44 Suppl 10: 1-59.
29. Sambrook J., Fritsch E. F., Maniatis T., Molecular cloning: A laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory, 1982.
30. StataCorp. Stata Statistical Software: Release 9.0 College Station. TX: Stata Corporation 2001)
31. Oh DY, Schumann RR, Hamann L, Neumann K, Worm M, Heine G,. Association of the toll-like receptor 2 A-16934T promoter polymorphism with severe atopic dermatitis. Allergy 2009; 64 (11): 1608-15.
32. Potaczek DP, Nastalek M, Okumura K, Wojas-Pelc A, Undas A, Nishiyama C, et al. An association of TLR2-16934A>T polymorphism and severity/phenotype of atopic dermatitis. J Eur Acad Dermatol Venereol 2010 Jun 20. doi: 10.1111/j.l468-3083.2010.03812.x.
33. Kormann MS, Ferstl R, Depner M, Klopp N, Spiller S, Illig T, et al. Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk. A llergy. 2009; 64 (4): 636-42.
34. Niebuhr M, Langnickel J, Draing C, Renz H, Kapp A, Werfel T,. Dysregulation of toll-like receptor-2 (TLR-2)-induced effects in monocytes from patients with atopic dermatitis: Impact of the TLR-2 R753Q polymorphism. Allergy 2008; 63 (6): 728-34.
35. Weidinger S, Novak N, Klopp N, Baurecht H, Wagenpfeil S, Rummler L, Ring J, et al. Lack of association between Tolllike receptor 2 and Toll-like receptor 4 polymorphisms and atopic eczema. J Allergy Clin Immunol 2006; 118 (1): 277-9.
36. Smit LA, Bongers SI, Ruven HJ, Rijkers GT, Wouters IM, Heederik D, et al. Atopy and new-onset asthma in young Danish farmers and CD 14, TLR2, and TLR4 genetic polymorphisms: A nested case-control study. Clin Exp Allergy 2007; 37 (11): 1602-8.
37. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, Ogawa T, et al. Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 1999; 11 (4): 443-51.
38. Mrabet-Dahbi S, Dalpke AH, Niebuhr M, Frey M, Draing C, Brand S, et al. The Toll-like receptor 2 R753Q mutation modifies cytokine production and Toll-like receptor expression in atopic dermatitis. J Allergy Clin Immunol 2008; 121 (4): 1013-9.
39. Williams LK, Ownby DR, Maliarik MJ, Johnson CC,. The role of endotoxin and its receptors in allergic disease. Ann Allergy Asthma Immunol 2005; 94 (3): 323-32.
40. Lorenz E, Mira JP, Frees KL, Schwartz DA,. Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock. Arch Intern Med 2002; 162 (9): 1028-32.
41. Arbour NC, Lorenz E, Schutte BC, Zabner J, Kline JN, Jones M, et al. TLR4 mutations are associated with endotoxin hyporesponsiveness in humans. Nat Genet 2000; 25 (2): 187-91.